In the issue of Chimica Oggi – Chemistry Today 1/2022, we are pleased to have participated in the peptides panel discussion as a part of Peptide Drug Discovery and Process Development Perspectives. Simrat Singh, Ph.D., President of Ambio, Inc., discusses the “Regulatory Aspects for Peptides”. The regulatory pathway for peptide drug substances is complex and ever evolving and we look forward to being a part of the progress.
We invite you to read the panel discussion linked here:
Regulatory Aspects for Peptides
Content originally posted on the AmbioPharm website and shared with permission.